Trinity Biotech ROA 2010-2024 | TRIB

Current and historical return on assets (ROA) values for Trinity Biotech (TRIB) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Trinity Biotech ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2024-12-31 $-0.03B $0.10B -33.33%
2024-09-30 $-0.02B $0.10B -24.71%
2024-06-30 $-0.02B $0.09B -29.97%
2024-03-31 $-0.02B $0.09B -30.88%
2023-12-31 $-0.03B $0.06B -34.97%
2023-09-30 $-0.03B $0.06B -36.36%
2023-06-30 $-0.03B $0.07B -35.13%
2023-03-31 $-0.04B $0.09B -36.08%
2022-12-31 $-0.04B $0.09B -40.69%
2022-09-30 $-0.03B $0.10B -29.77%
2022-06-30 $-0.02B $0.11B -19.34%
2022-03-31 $-0.01B $0.11B -10.99%
2021-12-31 $0.00B $0.12B 0.80%
2021-09-30 $-0.01B $0.12B -6.23%
2021-06-30 $0.00B $0.13B -1.52%
2021-03-31 $0.00B $0.14B -1.51%
2020-12-31 $-0.01B $0.13B -4.58%
2020-09-30 $-0.02B $0.14B -14.48%
2020-06-30 $-0.03B $0.13B -18.51%
2020-03-31 $-0.03B $0.13B -19.83%
2019-12-31 $-0.03B $0.13B -17.26%
2019-09-30 $-0.03B $0.17B -17.31%
2019-06-30 $-0.03B $0.17B -16.47%
2019-03-31 $-0.02B $0.17B -12.54%
2018-12-31 $-0.02B $0.15B -12.15%
2018-09-30 $-0.04B $0.18B -21.44%
2018-06-30 $-0.04B $0.19B -20.31%
2018-03-31 $-0.04B $0.20B -19.13%
2017-12-31 $-0.04B $0.19B -17.67%
2017-09-30 $-0.10B $0.25B -40.20%
2017-06-30 $-0.10B $0.25B -36.36%
2017-03-31 $-0.10B $0.25B -32.65%
2016-12-31 $-0.10B $0.25B -30.42%
2016-09-30 $0.00B $0.36B 0.83%
2016-06-30 $0.02B $0.36B 4.45%
2016-03-31 $0.02B $0.36B 4.73%
2015-12-31 $0.02B $0.36B 6.64%
2015-09-30 $0.02B $0.36B 7.63%
2015-06-30 $0.02B $0.36B 5.52%
2015-03-31 $0.02B $0.25B 6.63%
2014-12-31 $0.02B $0.24B 6.76%
2014-09-30 $0.02B $0.24B 7.31%
2014-06-30 $0.01B $0.24B 4.37%
2014-03-31 $0.01B $0.23B 4.54%
2013-12-31 $0.01B $0.23B 4.68%
2013-09-30 $0.01B $0.22B 4.36%
2013-06-30 $0.02B $0.20B 8.07%
2013-03-31 $0.02B $0.20B 8.27%
2012-12-31 $0.02B $0.20B 8.50%
2012-09-30 $0.02B $0.19B 8.80%
2012-06-30 $0.02B $0.18B 9.05%
2012-03-31 $0.02B $0.18B 9.26%
2011-12-31 $0.02B $0.17B 9.48%
2011-09-30 $0.02B $0.17B 9.62%
2011-06-30 $0.02B $0.17B 9.19%
2011-03-31 $0.06B $0.17B 38.87%
2010-12-31 $0.06B $0.16B 40.40%
2010-09-30 $0.06B $0.16B 41.74%
2010-06-30 $0.06B $0.15B 43.88%
2010-03-31 $0.01B $0.13B 9.14%
2009-12-31 $0.01B $0.13B 9.27%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.013B $0.062B
Trinity Biotech plc, headquartered in Bray, the Republic of Ireland, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market worldwide. The company provides two haemostasis product lines, Biopool and Amax, comprising test kits and instrumentation used for the detection of blood disorders. These products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the blood, liver and intestine. The Company is also a provider of raw materials to the life sciences industry. It also engages in the provision of engineering, financial, and management services, as well as in trading business. Trinity Biotech sells its products through its sales force, as well as through a network of distributors and strategic partners.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $209.668B 24.59
Boston Scientific (BSX) United States $154.824B 38.76
Stryker (SYK) United States $148.439B 31.04
EssilorLuxottica (ESLOY) France $131.494B 0.00
Medtronic (MDT) Ireland $114.826B 16.28
Lonza Group Ag (LZAGY) Switzerland $49.743B 0.00
Haleon (HLN) United Kingdom $43.081B 24.59
ResMed (RMD) United States $37.598B 28.24
GE HealthCare Technologies (GEHC) United States $34.909B 16.57
Agilent Technologies (A) United States $33.054B 21.55
Terumo (TRUMY) Japan $24.345B 31.62
Koninklijke Philips (PHG) Netherlands $23.697B 16.63
Insulet (PODD) United States $19.948B 78.30
Zimmer Biomet Holdings (ZBH) United States $18.776B 12.06
Baxter (BAX) United States $14.312B 10.69
Smith & Nephew SNATS (SNN) United Kingdom $13.087B 0.00
Sunny Optical Technology (SNPTF) China $10.417B 0.00
Demant (WILYY) Denmark $8.633B 0.00
Bio-Rad Laboratories (BIO) United States $6.794B 23.64
Lantheus Holdings (LNTH) United States $5.092B 12.85
Perrigo (PRGO) Ireland $3.733B 9.46
Prestige Consumer Healthcare (PBH) United States $3.713B 16.58
Haemonetics (HAE) United States $3.529B 16.07
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.347B 27.82
ICU Medical (ICUI) United States $3.070B 22.64
LeMaitre Vascular (LMAT) United States $1.855B 41.47
QuidelOrtho (QDEL) United States $1.804B 12.41
AtriCure (ATRC) United States $1.473B 0.00
Acuren (TIC) United States $1.444B 0.00
AdaptHealth (AHCO) United States $1.242B 12.60
Green Thumb Industries (GTBIF) United States $1.207B 27.14
Phibro Animal Health (PAHC) United States $1.205B 15.40
Neogen (NEOG) United States $1.055B 13.50
BioLife Solutions (BLFS) United States $1.025B 0.00
InMode (INMD) Israel $0.891B 8.98
Kestra Medical Technologies (KMTS) United States $0.845B 0.00
Curaleaf Holdings (CURLF) Canada $0.674B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.639B 0.00
Owens & Minor (OMI) United States $0.617B 5.12
Tilray Brands (TLRY) Canada $0.615B 0.00
Evolus (EOLS) United States $0.602B 0.00
CeriBell (CBLL) United States $0.565B 0.00
Valneva SE (VALN) France $0.553B 0.00
Surmodics (SRDX) United States $0.438B 0.00
SNDL (SNDL) Canada $0.410B 0.00
Capricor Therapeutics (CAPR) United States $0.327B 0.00
VAREX IMAGING (VREX) United States $0.323B 11.89
Sanuwave Health (SNWV) United States $0.321B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.304B 0.00
Quanterix (QTRX) United States $0.275B 0.00
Cresco Labs (CRLBF) United States $0.270B 0.00
Viemed Healthcare (VMD) United States $0.264B 22.23
Cerus (CERS) United States $0.262B 0.00
Aurora Cannabis (ACB) Canada $0.256B 75.83
OraSure Technologies (OSUR) United States $0.245B 0.00
Sanara MedTech (SMTI) United States $0.244B 0.00
ZimVie (ZIMV) United States $0.241B 10.96
Biote (BTMD) United States $0.228B 6.42
Brainsway (BWAY) Israel $0.219B 58.05
Verano Holdings (VRNOF) United States $0.204B 0.00
Canopy Growth (CGC) Canada $0.204B 0.00
Omeros (OMER) United States $0.204B 0.00
High Tide (HITI) Canada $0.203B 0.00
Organigram Global (OGI) Canada $0.196B 0.00
Utah Medical Products (UTMD) United States $0.182B 14.82
TriSalus Life Sciences (TLSI) United States $0.179B 0.00
Exagen (XGN) United States $0.153B 0.00
Vireo Growth (VREOF) United States $0.150B 0.00
FitLife Brands (FTLF) United States $0.125B 15.33
TerrAscend (TSNDF) Canada $0.107B 0.00
Jin Medical (ZJYL) China $0.101B 0.00
Fonar (FONR) United States $0.099B 12.74
MacroGenics (MGNX) United States $0.097B 0.00
Veru (VERU) United States $0.090B 0.00
Quipt Home Medical (QIPT) United States $0.090B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Apyx Medical (APYX) United States $0.086B 0.00
Jushi Holdings (JUSHF) United States $0.081B 0.00
Zynex (ZYXI) United States $0.071B 0.00
Agape ATP (ATPC) $0.071B 0.00
InterCure (INCR) Israel $0.068B 0.00
Cytosorbents (CTSO) United States $0.062B 0.00
ImmuCell (ICCC) United States $0.060B 0.00
Safety Shot (SHOT) United States $0.052B 0.00
United-Guardian (UG) United States $0.042B 14.54
Nephros (NEPH) United States $0.038B 51.14
Modular Medical (MODD) United States $0.038B 0.00
Rockwell Medical (RMTI) United States $0.037B 0.00
Allurion Technologies (ALUR) United States $0.022B 0.00
INLIF (INLF) $0.016B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Meihua Medical Technologies (MHUA) China $0.014B 0.00
IM Cannabis (IMCC) Canada $0.014B 0.00
Senestech (SNES) United States $0.011B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
Innovative Eyewear (LUCY) United States $0.007B 0.00
Sharps Technology (STSS) United States $0.006B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00